Emcure Pharmaceuticals Limited
NSE: EMCURE | Information Technology
Market Fundamentals
Stock Intelligence & News
20 stocks in focus today: Signature Global, IndusInd Bank, pharma, railway and power counters
From Signature Global’s ₹920-crore construction contracts to IndusInd Bank’s RBI approval for a stockbroking subsidiary, today’s watchlist features major updates across real estate, banking, pharma, railways and clean energy, with NBCC, RITES and Emcure Pharma also in focus.
Read Full Analysis →Emcure Pharmaceuticals Limited
Update on USFDA inspection at our formulations facility located at Sanand, Ahmedabad, Gujarat, India. |SUBJECT: General Updates
Read Full Analysis →Q1 Results Today Live: SBI, Titan, Hindalco, Hitachi Energy, PFC, Godrej Consumer, Oil India, NLC, Kaynes Tech, Ramco Cements, Afcons Infra, Lemon Tree, Cello to announce Q1 results, Trent, Hero Motocorp, Lupin, LIC, Bosch, Premier Energies, Emcure, Blue Star, Siemens Energy in focus
Q1 Results Today, 07th August 2026 Live Updates: Follow Q1FY27 live updates from businessline
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Emcure Pharmaceuticals Limited
Emcure Pharmaceuticals Limited has informed the Exchange that Record date as September 04, 2026, for the purpose of Final Dividend for the financial year ended March 31, 2026, subject to approval of members. |SUBJECT: Record Date
Read Full Analysis →Emcure Pharmaceuticals Ltd (544210)
Intimation of date of the 45th Annual General Meeting and Record Date for payment of Final Dividend on Equity Shares for the Financial Year March 31, 2026
Read Full Analysis →Emcure Pharmaceuticals Limited
Emcure Pharmaceuticals Limited has informed the Exchange about change in Management |SUBJECT: Change in Management
Read Full Analysis →Emcure Pharmaceuticals Ltd (544210)
Presentation on Unaudited Financial Results for the quarter ended June 30, 2026
Read Full Analysis →Emcure Pharmaceuticals Limited
Emcure Pharmaceuticals Limited has informed the Exchange about Investor Presentation |SUBJECT: Investor Presentation
Read Full Analysis →Emcure Pharmaceuticals Limited
Emcure Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026. |SUBJECT: Outcome of Board Meeting
Read Full Analysis →Emcure Pharma Q1: Net Profit Jumps 42%; CEO Satish Mehta Appointed As Chairman
Emcure Pharma Q1 Results
Read Full Analysis →Get instant alerts when EMCURE breaks news
Join investors who track Emcure Pharmaceuticals Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for EMCURE?
EMCURE is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Emcure Pharmaceuticals Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding EMCURE to your custom watchlist.